Bonkers Bitcoin heist: 5-star hotels, cash-filled envelopes, vanishing funds

Bonkers Bitcoin heist: 5-star hotels, cash-filled envelopes, vanishing funds

fivenewscrypto    novembre 19, 2025   

As Kent Halliburton stood in a bathroom at the Rosewood Hotel in central Amsterdam, thousands of miles from home, running his fingers through an envelope filled with 10,000 euros in crisp banknotes, he started to wonder what he had gotten himself into.

Halliburton is the cofounder and CEO of Sazmining, a company that operates bitcoin mining hardware on behalf of clients—a model known as “mining-as-a-service.” Halliburton is based in Peru, but Sazmining runs mining hardware out of third-party data centers across Norway, Paraguay, Ethiopia, and the United States.

As Halliburton tells it, he had flown to Amsterdam the previous day, August 5, to meet Even and Maxim, two representatives of a wealthy Monaco-based family. The family office had offered to purchase hundreds of bitcoin mining rigs from Sazmining—around $4 million worth—which the company would install at a facility currently under construction in Ethiopia. Before finalizing the deal, the family office had asked to meet Halliburton in person.

Read full article

Comments

Trump admin axed 383 active clinical trials, dumping over 74K participants

Trump admin axed 383 active clinical trials, dumping over 74K participants

fivenewscrypto    novembre 19, 2025   

When the Trump administration brutally cut federal funding for biomedical research earlier this year, at least 383 clinical trials that were already in progress were abruptly canceled, cutting off over 74,000 trial participants from their experimental treatments, monitoring, or follow-ups, according to a study published today in JAMA Internal Medicine.

The study, led by researchers at Harvard, fills a knowledge gap of how the Trump administration’s research funding cuts affected clinical trials specifically. It makes clear not just the wastefulness and inefficiency of the cuts but also the deep ethical violations, JAMA Internal Medicine editors wrote in an accompanying editor’s note.

In March, the National Institutes of Health, under the control of the Trump administration, announced that it would cancel $1.8 billion in grant funding that wasn’t aligned with the administration’s priorities. The Harvard researchers, led by health care policy expert Anupam Jena, used an NIH database and a federal accountability tracking tool to find grants supporting clinical trials that were active as of February 28 but had been terminated by August 15.

Read full article

Comments

With a new company, Jeff Bezos will become a CEO again

With a new company, Jeff Bezos will become a CEO again

fivenewscrypto    novembre 19, 2025   

Jeff Bezos is one of the world’s richest and most famous tech CEOs, but he hasn’t actually been a CEO of anything since 2021. That’s now changing as he takes on the role of co-CEO of a new AI company, according to a New York Times report citing three people familiar with the company.

Grandiosely named Project Prometheus (and not to be confused with the NASA project of the same name), the company will focus on using AI to pursue breakthroughs in research, engineering, manufacturing, and other fields that are dubbed part of “the physical economy”—in contrast to the software applications that are likely the first thing most people in the general public think of when they hear “AI.”

Bezos’ co-CEO will be Vik Bajaj, a chemist and physicist who previously led life sciences work at Google X, an Alphabet-backed research group that worked on speculative projects that could lead to more product categories. (For example, it developed technologies that would later underpin Google’s Waymo service.) Bajaj also worked at Verily, another Alphabet-backed research group focused on life sciences, and Foresite Labs, an incubator for new AI companies.

Read full article

Comments

Judge smacks down Texas AG’s request to immediately block Tylenol ads

Judge smacks down Texas AG’s request to immediately block Tylenol ads

fivenewscrypto    novembre 19, 2025   

A Texas Judge has rejected a request from Texas Attorney General Ken Paxton to issue a temporary order barring Tylenol’s maker, Kenvue, from claiming amid litigation that the pain and fever medication is safe for pregnant women and children, according to court documents.

In records filed Friday, District Judge LeAnn Rafferty, in Panola County, also rejected Paxton’s unusual request to block Kenvue from distributing $400 million in dividends to shareholders later this month.

The denials are early losses for Paxton in a politically charged case that hinges on the unproven claim that Tylenol causes autism and other disorders—a claim first introduced by President Trump and his anti-vaccine health secretary, Robert F. Kennedy Jr.

Read full article

Comments

After last week’s stunning landing, here’s what comes next for Blue Origin

After last week’s stunning landing, here’s what comes next for Blue Origin

fivenewscrypto    novembre 19, 2025   

For decades—yes, literally decades—it has been easy to dismiss Blue Origin as a company brimming with potential but rarely producing much of consequence.

But last week the company took a tremendous stride forward, not just launching its second orbital rocket, but subsequently landing the booster on a barge named Jacklyn. It now seems clear that Blue Origin is in the midst of a transition from sleeping giant to force to be reckoned with.

To get a sense of where the company goes from here, Ars spoke with the company’s chief executive, Dave Limp, on the eve of last week’s launch. The first thing he emphasized is how much the company learned about New Glenn, and the process of rolling the vehicle out and standing it up for launch, from the vehicle’s first attempt in January.

Read full article

Comments

Report claims that Apple has yet again put the Mac Pro “on the back burner”

Report claims that Apple has yet again put the Mac Pro “on the back burner”

fivenewscrypto    novembre 19, 2025   

Apple’s Power Mac and Mac Pro towers used to be the company’s primary workstations, but it has been years since they were updated with the same regularity as the MacBook Air or MacBook Pro. The Mac Pro has seen just four hardware updates in the last 15 years, and that’s counting a 2012 refresh that was mostly identical to the 2010 version.

Long-suffering Mac Pro buyers may have taken heart when Apple finally added an M2 Ultra processor to the tower in mid-2023, making it one of the very last Macs to switch from Intel to Apple Silicon—surely this would mean that the computer would at least be updated once every year or two, like the Mac Studio has been? But Bloomberg’s Mark Gurman says that Mac Pro buyers shouldn’t get their hopes up for new hardware in 2026.

Gurman says that the tower is “on the back burner” at Apple and that the company is “focused on a new Mac Studio” for the next-generation M5 Ultra chip that is in the works. As we reported earlier this year, Apple doesn’t have plans to design or release an M4 Ultra, and the Mac Studio refresh from this spring included an M3 Ultra alongside the M4 Max.

Read full article

Comments

Oracle hit hard in Wall Street’s tech sell-off over its huge AI bet

Oracle hit hard in Wall Street’s tech sell-off over its huge AI bet

fivenewscrypto    novembre 18, 2025   

Oracle has been hit harder than Big Tech rivals in the recent sell-off of tech stocks and bonds, as its vast borrowing to fund a pivot to artificial intelligence unnerved Wall Street.

The US software group founded by Larry Ellison has made a dramatic entrance to the AI race, committing to spend hundreds of billions of dollars in the next few years on chips and data centers—largely as part of deals to supply computing capacity to OpenAI, the maker of ChatGPT.

The speed and scale of its moves have unsettled some investors at a time when markets are keenly focused on the spending of so-called hyperscalers—big tech companies building vast data centers.

Read full article

Comments